{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:04:12Z","timestamp":1784070252880,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10096-021-04392-2","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:03:15Z","timestamp":1641168195000},"page":"421-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5225-8319","authenticated-orcid":false,"given":"Bircan","family":"Kayaaslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Hasanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Kaya","family":"Kalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Eser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmet","family":"Guner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"issue":"4","key":"4392_CR1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5897\/AJMR2013.6409","volume":"8","author":"I Jamil","year":"2014","unstructured":"Jamil I, Zafar A, Qamar MU, Ejaz H, Akhtar J, Waheed A (2014) Multi-drug resistant Klebsiella pneumoniae causing urinary tract infections in children in Pakistan. Afr J Microbiol Res 8(4):316\u2013319. https:\/\/doi.org\/10.5897\/AJMR2013.6409","journal-title":"Afr J Microbiol Res"},{"key":"4392_CR2","first-page":"78","volume":"2","author":"N Ramesh","year":"2008","unstructured":"Ramesh N, ve Sumathi CS, (2008) Urinary tract infection and antimicrobial susceptibility pattern of extended spectrum of beta lactamase producing clinical isolates. Biol Res 2:78\u201382","journal-title":"Biol Res"},{"key":"4392_CR3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.biopha.2017.08.006","volume":"94","author":"S Khoshnood","year":"2017","unstructured":"Khoshnood S, Heidary M, Mirnejad R, Bahramian A, Sedighi M, Mirzaei H (2017) Drug-resistant gram-negative uropathogens: a review. Biomed Pharmacother 94:982\u2013994. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.006","journal-title":"Biomed Pharmacother"},{"key":"4392_CR4","doi-asserted-by":"publisher","unstructured":"Nicolle LE, and AMMI Canada Guidelines Committee* (2005). Complicated urinary tract infection in adults.\u00a0The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale,\u00a016(6):349\u2013360. https:\/\/doi.org\/10.1155\/2005\/385768","DOI":"10.1155\/2005\/385768"},{"key":"4392_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","volume":"39","author":"S Meier","year":"2011","unstructured":"Meier S, Weber R, Zbinden R, Ruef C, Hasse B (2011) Extended-spectrum \u03b2-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: An increasing challenge for antimicrobial therapy. Infection 39:333\u2013340","journal-title":"Infection"},{"issue":"1","key":"4392_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1086\/649537","volume":"50","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2010","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Pic\u00f3n E, Gij\u00f3n P, Hern\u00e1ndez JR, Ru\u00edz M, Pe\u00f1a C, Almela M, Almirante B, Grill F, Colomina J, Gim\u00e9nez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A, Spanish Network for Research in Infectious Diseases (REIPI) (2010) Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50(1):40\u20138. https:\/\/doi.org\/10.1086\/649537","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4392_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1469-0691.2005.01358.x","volume":"12","author":"C Pe\u00f1a","year":"2006","unstructured":"Pe\u00f1a C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, Calatayud L, Ariza J, Gudiol F (2006) Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect 12(3):279\u2013284. https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01358.x","journal-title":"Clin Microbiol Infect"},{"key":"4392_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:103\u2013120","journal-title":"Clin Infect Dis"},{"key":"4392_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2018.04.012","volume":"92","author":"HS Sader","year":"2018","unstructured":"Sader HS, Castanheira M, Duncan LR, ve Flamm RK (2018) Antimicrobial susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa isolates from United States medical centers stratified by infection type: results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015\u20132016. Diagn Microbiol Infect Dis 92:69\u201374","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4392_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1159\/000049840","volume":"40","author":"KG Naber","year":"2003","unstructured":"Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Cruz FJ, Selvaggi FP (2003) EAU guidelines for the management of urinary and male genital tract infections1. Eur Urol 40:576\u2013588","journal-title":"Eur Urol"},{"key":"4392_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1086\/650482","volume":"50","author":"TM Hooton","year":"2010","unstructured":"Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P et al (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis 50:625\u2013663","journal-title":"Clin Infect Dis"},{"key":"4392_CR12","unstructured":"Sobel JD, Brown P (2020) Mandell, Douglas, and Bennett\u2019s Principles and... I\u00e7inde Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, E. John, M. Bennett, M. Rapheal Dolin, ve M. Martin J. Blaser, ed., ss. 962\u201389"},{"key":"4392_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/fmb-2016-0145","volume":"12","author":"A Guglietta","year":"2017","unstructured":"Guglietta A (2017) Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol 12:239\u2013246","journal-title":"Future Microbiol"},{"key":"4392_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA - J Am Med Assoc 315:801\u2013810","journal-title":"JAMA - J Am Med Assoc"},{"issue":"5","key":"4392_CR15","first-page":"933","volume":"71","author":"K Ramakrishnan","year":"2005","unstructured":"Ramakrishnan K, Scheid DC (2005) Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 71(5):933\u2013942","journal-title":"Am Fam Physician"},{"issue":"12","key":"4392_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1741-7015-12-40","volume":"6","author":"T Cardoso","year":"2014","unstructured":"Cardoso T, Almeida M, Friedman ND, Arag\u00e3o I, Costa-Pereira A, Sarmento AE, Azevedo L (2014) Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med 6(12):40. https:\/\/doi.org\/10.1186\/1741-7015-12-40","journal-title":"BMC Med"},{"issue":"3","key":"4392_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infec 18(3):268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infec"},{"key":"4392_CR18","unstructured":"Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; M100, CLSI, (2013\u20132016). Available from:\u00a0https:\/\/clsi.org\/media\/2663\/m100ed29_sample.pdf.\u00a0Accessed 18 May 2021"},{"key":"4392_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269\u2013284","journal-title":"Nat Rev Microbiol"},{"key":"4392_CR20","doi-asserted-by":"publisher","unstructured":"Doron S, Davidson LE (2011) Antimicrobial stewardship. Mayo Clin Proc 86, 1113\u20131123. Available at: https:\/\/doi.org\/10.4065\/mcp.2011.0358","DOI":"10.4065\/mcp.2011.0358"},{"key":"4392_CR21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrurol.2010.190","volume":"7","author":"B Foxman","year":"2010","unstructured":"Foxman B (2010) The epidemiology of urinary tract infection. Nat Rev Urol 7:653\u2013660. https:\/\/doi.org\/10.1038\/nrurol.2010.190","journal-title":"Nat Rev Urol"},{"key":"4392_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0195-6701(98)90274-2","volume":"38","author":"R Finkelstein","year":"1998","unstructured":"Finkelstein R, Kassis E, Reinhertz G, Gorenstein S, ve Herman, P. (1998) Community-acquired urinary tract infection in adults: a hospital viewpoint. J Hosp Infect 38:193\u2013202","journal-title":"J Hosp Infect"},{"issue":"5","key":"4392_CR23","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/jac\/dki344","volume":"56","author":"H Arslan","year":"2005","unstructured":"Arslan H, Azap OK, Erg\u00f6n\u00fcl O, Timurkaynak F, Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56(5):914\u20138. https:\/\/doi.org\/10.1093\/jac\/dki344","journal-title":"J Antimicrob Chemother"},{"key":"4392_CR24","unstructured":"Antimicrobial resistance. Policy insights. https:\/\/www.oecd.org\/health\/health-systems\/AMR-Policy-Insights-November2016.pdf. Access date 02 Feb 2021."},{"key":"4392_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","volume":"16","author":"\u00d6K Azap","year":"2010","unstructured":"Azap \u00d6K, Arslan H, \u015eerefhano\u011dlu K, \u00c7olako\u011dlu \u015e, Erdo\u011dan H, Timurkaynak F, Senger SS (2010) Risk factors for extended-spectrum \u03b2-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 16:147\u2013151","journal-title":"Clin Microbiol Infect"},{"key":"4392_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2967260","volume":"2020","author":"MG Zavala-Cerna","year":"2020","unstructured":"Zavala-Cerna MG, Segura-Cobos M, Gonzalez R, Zavala-Trujillo IG, Navarro-Perez SF, Rueda-Cruz JA, Satoscoy-Tovar FA (2020) The clinical significance of high antimicrobial resistance in community-acquired urinary tract infections. Can J Infect Dis Med Microbiol 2020:1\u20137","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"4392_CR27","doi-asserted-by":"publisher","unstructured":"Alshareef H, Alfahad W, Albaadani A, Alyazid H, Talib RB (2020). Impact of antibiotic de-escalation on hospitalized patients with urinary tract infections: a retrospective cohort single center study. J. Infect. Public Health 13, 985\u2013990. Available at: https:\/\/doi.org\/10.1016\/j.jiph.2020.03.004","DOI":"10.1016\/j.jiph.2020.03.004"},{"key":"4392_CR28","doi-asserted-by":"publisher","unstructured":"Gupta K, Bhadelia N (2014) Management of urinary tract infections from multidrug-resistant organisms. Infect Dis Clin North Am 28, 49\u201359. Available at: https:\/\/doi.org\/10.1016\/j.idc.2013.10.002","DOI":"10.1016\/j.idc.2013.10.002"},{"key":"4392_CR29","first-page":"236","volume":"5","author":"S Umadevi","year":"2011","unstructured":"Umadevi S, Kandhakumari G, Joseph NM, Kumar S, Easow JM, Stephen S, Singh UK (2011) Prevalence and antimicrobial susceptibility pattern of ESBL producing gram negative bacilli. J Clin Diagnostic Res 5:236\u2013239","journal-title":"J Clin Diagnostic Res"},{"key":"4392_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/jac\/dkl035","volume":"57","author":"E Calbo","year":"2006","unstructured":"Calbo E, Roman\u00ed V, Xercavins M, G\u00f3mez L, Vidal GC, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum \u03b2-lactamases. J Antimicrob Chemother 57:780\u2013783","journal-title":"J Antimicrob Chemother"},{"key":"4392_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5152\/kd.2019.68","volume":"32","author":"D Karamanl\u0131o\u011flu","year":"2019","unstructured":"Karamanl\u0131o\u011flu D, Aysert-Y\u0131ld\u0131z P, Kaya M, Sar\u0131 N (2019) Extended-spectrum \u03b2-lactamase production rates and antibiotic susceptibilities among Enterobacteriaceae isolated from urine cultures. Klimik Derg 32:233\u2013239","journal-title":"Klimik Derg"},{"key":"4392_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/604713","volume":"49","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Rodr\u00edguez-Ba\u00f1o J, Arslan H, Pitout JDD, Quentin C, Caibo ES, Azap \u00d6K, Arpin C, Pascual A, Livermore DM et al (2009) A multinational survey of risk factors for infection with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49:682\u2013690","journal-title":"Clin Infect Dis"},{"key":"4392_CR33","doi-asserted-by":"crossref","unstructured":"Sierra-D\u00edaz E, Hern\u00e1ndez-R\u00edos CJ, Bravo-Cuellar A (2019). Antibiotic resistance: microbiological profile of urinary tract infections in Mexico. Cir y Cir (English Ed. 87, 176\u2013182.","DOI":"10.24875\/CIRU.18000494"},{"key":"4392_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5505\/TurkHijyen.2019.57984","volume":"77","author":"D Mert","year":"2020","unstructured":"Mert D, \u00c7eken S, Ertek M (2020) The isolated bacteria from culture and antibiotic susceptibilities in urinary tract infections. Turk Hij ve Deney Biyol Derg 77:25\u201332","journal-title":"Turk Hij ve Deney Biyol Derg"},{"issue":"9","key":"4392_CR35","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/pds.5311s","volume":"30","author":"M Aksoy","year":"2021","unstructured":"Aksoy M, Isli F, Kadi E, Varimli D, Gursoz H, Tolunay T, Kara A, Unal S, Alp ME (2021) Evaluation of more than one billion outpatient prescriptions and eight-year trend showing a remarkable reduction in antibiotic prescription in Turkey: a success model of governmental interventions at national level. Pharmacoepidemiol Drug Saf 30(9):1242\u20131249. https:\/\/doi.org\/10.1002\/pds.5311s","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4392_CR36","unstructured":"Antimicrobial resistance. Policy insights. https:\/\/www.oecd.org\/health\/health-systems\/AMR-Policy-Insights-November2016.pdf. 30 August 2021."},{"issue":"5","key":"4392_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1473-3099(14)70071-4","volume":"14","author":"A Versporten","year":"2014","unstructured":"Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, Carp A, Radonjic V, Maqsudova N, Celik HD, Payerl-Pal M, Pedersen HB, Sautenkova N, Goossens H, WHO\/Europe-ESAC Project Group (2014) Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis. 14(5):381\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(14)70071-4","journal-title":"Lancet Infect Dis."},{"issue":"10","key":"4392_CR38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791\u2013797. https:\/\/doi.org\/10.7326\/0003-4819-137-10-200211190-00007","journal-title":"Ann Intern Med"},{"key":"4392_CR39","doi-asserted-by":"publisher","unstructured":"Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128(6):3854\u20133862.\u00a0https:\/\/doi.org\/10.1378\/chest.128.6.3854.\u00a0\u00a0Erratum in: Chest. 2006 Mar;129(3):831","DOI":"10.1378\/chest.128.6.3854"},{"issue":"5","key":"4392_CR40","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jac\/dkm318","volume":"60","author":"MJ Schwaber","year":"2007","unstructured":"Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60(5):913\u2013920. https:\/\/doi.org\/10.1093\/jac\/dkm318","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"4392_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ijantimicag.2010.05.009","volume":"36","author":"Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY; Korean Network for Study of Infectious Diseases (KONSID)","year":"2010","unstructured":"Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY; Korean Network for Study of Infectious Diseases (KONSID) (2010) Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 36(3):284\u2013287. https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.05.009","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"4392_CR42","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10096-019-03528-9","volume":"38","author":"SH Kim","year":"2019","unstructured":"Kim SH, Oh S, Huh K, Cho SY, Kang CI, Chung DR, Peck KR (2019) Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriales. Eur J Clin Microbiol Infect Dis 38(5):937\u2013944. https:\/\/doi.org\/10.1007\/s10096-019-03528-9","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04392-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T13:14:10Z","timestamp":1644498850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04392-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["4392"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04392-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was received from Ankara City Hospital Ethics Committee 1 (Decision number: E1\/1565\/2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}